COVID-19 convalescent plasma therapy for immunodeficient patients–weighing up risks and benefits (CROSBI ID 299921)
Prilog u časopisu | Pismo uredniku | međunarodna recenzija
Podaci o odgovornosti
Vuk, Tomislav ; Hećimović, Ana ; Jukić, Irena ; Ravlić, Sanda ; Kurtović, Tihana ; Rnjak, Dina ; Halassy, Beata
engleski
COVID-19 convalescent plasma therapy for immunodeficient patients–weighing up risks and benefits
We would like to use the opportunity to discuss some of thesafety concerns of convalescent COVID- 19 plasma, raised by Mung-munpuntipantip and Wiwanitkit in their letter. We agree with the authors that risk- benefit analyses for the use of convalescentplasma are of great importance and contribute to the improvementof patient safety.
COVID-19 convalescent plasma ; immunodeficiency
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
28 (4)
2021.
424-425
objavljeno
1246-7820
10.1016/j.tracli.2021.06.001
Povezanost rada
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje), Javno zdravstvo i zdravstvena zaštita, Kliničke medicinske znanosti